Bank Of New York Mellon Corp Recursion Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $3.62 Million - $6.42 Million	505,447 New	505,447 $3.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $818,924 - $1.42 Million	104,588 Added 26.19%	503,941 $5.36 Million
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $129,291 - $237,546	25,653 Added 6.86%	399,353 $3.25 Million
Q1 2022 May 11, 2022	BUY	$6.16 - $18.03 $38,771 - $113,480	6,294 Added 1.71%	373,700 $2.68 Million
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $4.25 Million - $5.76 Million	263,379 Added 253.18%	367,406 $6.29 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $582,945 - $1.27 Million	30,633 Added 41.74%	104,027 $2.39 Million
Q2 2021 Aug 11, 2021	BUY	$18.0 - $37.42 $1.32 Million - $2.75 Million	73,394 New	73,394 $2.68 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.